These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9015780)
1. Specific immunotherapy in pollinosis: II. Forecasting changes in certain cytoimmunological indicators after four years of immunotherapy in pollinosis. Zieliński AE J Investig Allergol Clin Immunol; 1996; 6(6):364-70. PubMed ID: 9015780 [TBL] [Abstract][Full Text] [Related]
2. Specific immunotherapy in pollinosis: I. Valuation of certain cytoimmunological indicators over the course of four years of immunotherapy in pollinosis. Zieliński AE J Investig Allergol Clin Immunol; 1996; 6(5):307-14. PubMed ID: 8959542 [TBL] [Abstract][Full Text] [Related]
3. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma. Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776 [TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy for Japanese cedar pollinosis. Okubo K; Gotoh M Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236 [TBL] [Abstract][Full Text] [Related]
5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
6. Antigen-specific immunotherapy against allergic rhinitis: the state of the art. Fujimura T; Okamoto Y Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851 [TBL] [Abstract][Full Text] [Related]
7. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. Hylander T; Latif L; Petersson-Westin U; Cardell LO J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of various types of immunotherapy with gramineal pollens. II. Variation of humoral immunochemical parameters. Miguel Lozano R; Guerra Pasadas F; Arenas Vacas A; Daza Muñoz JC; Torres Murillo P; Sánchez Guijo P Allergol Immunopathol (Madr); 1992; 20(6):235-9. PubMed ID: 1296465 [TBL] [Abstract][Full Text] [Related]
9. [Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use)]. Bartosíková L; Necas J; Bartosík T; Pavlík M; Fránová J Ceska Slov Farm; 2008 Apr; 57(2):99-102. PubMed ID: 18578420 [TBL] [Abstract][Full Text] [Related]
10. A comparative immunological study of vasomotor rhinitis and pollinosis. Zieliński A J Investig Allergol Clin Immunol; 1996; 6(4):261-5. PubMed ID: 8844504 [TBL] [Abstract][Full Text] [Related]
11. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis. Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451 [TBL] [Abstract][Full Text] [Related]
12. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882 [TBL] [Abstract][Full Text] [Related]
13. Effects of enzyme-potentiated desensitization in the treatment of pollinosis: a double-blind placebo-controlled trial. Astarita C; Scala G; Sproviero S; Franzese A J Investig Allergol Clin Immunol; 1996; 6(4):248-55. PubMed ID: 8844502 [TBL] [Abstract][Full Text] [Related]
14. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation. Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924 [TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388 [TBL] [Abstract][Full Text] [Related]
17. Effect of hyposensitization for tree pollinosis on associated apple allergy. Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432 [TBL] [Abstract][Full Text] [Related]
18. [Influence of the difference in the pollen count on medical costs in an allergen-specific immunotherapy for Japanese cedar pollinosis]. Yuta A; Miyamoto Y; Hattori R; Ogihara H; Takeuchi K; Majima Y Arerugi; 2007 Nov; 56(11):1366-71. PubMed ID: 18059149 [TBL] [Abstract][Full Text] [Related]
19. [Therapy of allergic rhinitis]. Rasp G Laryngorhinootologie; 1993 Aug; 72(8):373-8. PubMed ID: 8104404 [TBL] [Abstract][Full Text] [Related]
20. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]